Global Market Study on Insulin Delivery Devices: Asia to Witness Highest Growth by 2020
Description
- Insulin
Delivery
Devices
Diabetes
is a disease characterized by high blood sugar levels. It is caused
by the improper functioning of the pancreas that secretes insulin.
Insulin is a hormone that maintains blood sugar levels in the body
and helps in the proper functioning of all cellular and physiological
activities. Diabetes is more common in the aged population; however,
incidence of diabetes is also increasing in children and adults. To
overcome this problem, insulin delivery devices, such as insulin
pens, pumps, syringes, and jet injectors, play a vital role in
maintaining insulin levels in the body. Insulin pens, syringes, and
pumps are devices that facilitate the delivery of insulin just under
the skin through a needle.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-market-study-on-insulin-delivery-devices-asia-to-witness-highest-growth-by-2020-report.html
Insulin
syringes are designed for self-administration of doses and have many
user-friendly features. For instance, these devices have short
needles that are less painful for the patient. Insulin pen comprises
insulin cartridge, dial and a needle. Insulin pen devices are used
with disposable needles for the delivery of insulin doses. The
compact design of these devices allows discreet administration of
insulin. Insulin pens are of two types: prefilled and reusable. A
prefilled pen is discarded once the contents of an insulin cartridge
are administered, whereas a reusable pen contains replaceable insulin
cartridges which are loaded and removed from the pen.
Insulin
pump is composed of a pump, a disposable reservoir to hold the
insulin, and a disposable infusion set, including cannula for
subcutaneous insertion of doses. An insulin pump can be worn
externally and clipped to wearers belt. Insulin jet injectors inject
insulin without the use of any needle. Insulin jets are composed of
three parts: a disposable injector nozzle, the delivery device shaped
like a pen, and a disposable insulin vial adapter.
Globally,
the increasing prevalence of diabetes and obesity are some major
drivers for the growth of the market. In addition, advanced features
of insulin delivery devices and rising awareness among people about
diabetes care are also supporting the growth of the global insulin
delivery devices market.
However,
risk and complications associated with the delivery of insulin and
high cost of insulin analog hamper the growth of the market.
Artificial pancreas and home infusion therapy are some of the major
trends of global insulin delivery devices market.
Under
geographic analysis, North America dominates the global insulin
delivery devices market due to increasing prevalence of diabetes and
rising number of overweight and obese people. The U.S. represents the
largest market for insulin delivery devices followed by Canada in
North America. Germany, France, the U.K., Italy and Spain holds major
share of insulin delivery devices market in Europe. However, Asia is
the fastest growing region in the global insulin delivery devices
market due to rising aging population. In addition, several
government initiatives are increasing awareness about diabetes
treatment which would increase the demand for insulin delivery
devices in the region.
The
global insulin delivery devices market report provides in-depth
analysis and estimation of the insulin delivery devices market from
2014 to 2020, considering 2014 as the base year for calculation.
Additionally, data pertaining to current market dynamics, including
market drivers, restraints, trends, and recent developments, has been
provided in the global insulin delivery devices market report.
Some
of the major players operating in the market are Abbott Laboratories,
Novo Nordisk A/S, Eli Lilly and Company, Medtronic, Inc., Sanofi,
Becton, Dickinson and Company, and F. Hoffmann-La Roche, Ltd. These
key market players have been profiled on the basis of attributes such
as company overview, recent developments, growth strategies,
sustainability and financial overview.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment